New chemical modification improves effectiveness and safety of ASO therapy for CNS diseases

FHS
May 23, 2024
2:48 pm

Diseases that affect the brain and spinal cord can be particularly devastating, and finding new and more effective ways to treat these conditions is an important goal for researchers and clinicians alike.

Pivotal bioVenture raises the stakes in biotech and pharmaceutical support – Pharmaceutical Technology

Share this article Fund II will allow Pivotal to continue funding the innovation of companies at all stages. Credit: Andrii Yalanskyi/Shutterstock.com Pivotal bioVenture Partners has

December 18, 2023

Should DOs and MDs Have Separate Licensing Boards? They Still Do in 13 States

Tom Takubo, DO, an osteopathic physician and pulmonary critical care specialist, is exasperated and crestfallen. Since 2017, the West Virginia state senator has questioned why

April 17, 2024

Aldeyra says its candidate won in chronic cough PhII, setting stage for bout with Merck, GSK

Aldeyra said that its therapy reduced cough frequency in patients with chronic cough in a Phase II study, as drugmakers focus on developing treatments for

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.